Law360, Wilmington (May 11, 2012, 3:52 PM ET) -- A Kensey Nash Corp. shareholder on Wednesday launched a proposed class action in Delaware state court to block the medical device firm's $360 million merger with Dutch food and chemicals maker DSM NV.
Lead plaintiff Hilary Conye claims Kensey Nash’s agreed-upon sales price of $38.50 per share is "woefully inadequate" and is a product of a flawed process designed to ensure the sale of the company on preferential terms to DSM at the expense of shareholders.
"Kensey Nash represents a highly attractive acquisition candidate," the complaint...
Investor Seeks To Block DSM's $360M Kensey Nash Buyout
To view the full article, take a free trial now.
